InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Browse the full record of transactions filed by Dowden Nathan J, Chief Operating Officer. Officer active across 1 companies, notably Entrada Therapeutics, Inc.. Aggregated, 4 filings have been published. Total volume traded: €95k. The latest transaction was filed on 4 May 2026 — Levée d'options. Regulator: SEC (Form 4). All data is free.
Declarations4 total
US$22,32315,000 shares@ US$1.48820.0090% mcap100.0% of flow
Common Stock
SEC:0001873392-26-000004·
€22,32315,000 shares@ €1.48820.0090% mcap16.0% of flow
Common Stock
SEC:0001873392-26-000004:0·
€94,7777,714 shares@ €12.28630.038% mcap68.0% of flow
Common Stock
SEC:0001104659-22-075788:0·
011,263 shares0
Common Stock
SEC:0001104659-22-030009:0·
4 of 4 declarations
About Dowden Nathan J
Nathan J. Dowden is the President and Chief Operating Officer of Entrada Therapeutics, Inc. In this role, he oversees the daily operations of the company and ensures the implementation of the business strategy. Dowden plays a key role in business development and process optimization, thereby contributing to Entrada's growth. His leadership is essential in ensuring the organization's success.
